Judge Bars Mylan's Oracea Generic In Galderma IP Case
A Delaware federal judge on Friday barred Mylan Pharmaceuticals Inc. from selling a generic version of Galderma Laboratories Inc.'s rosacea drug Oracea, even though the patent Mylan was found to have...To view the full article, register now.
Already a subscriber? Click here to view full article